Bicara Therapeutics Inc (BCAX)
R&D Expense Growth
-3.64%
Quarterly · Period ending:
BCAX R&D Expense Growth
Latest reported-3.64%period ending
Latest reported-3.64%period ending
BCAX Quarterly R&D Growth (QoQ) (0.00% → -3.64%)
Latest values, visible window
High-resolution chart · PNG
BCAX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -3.6358% | |
| 43.983% | |
| 467.1308% | |
| -76.5425% | |
| -27.7721% | |
| 72.6751% | |
| 25.3341% | |
| 0.1452% | |
| 31.6572% | |
| 13.9178% | |
| 52.2121% | |
| 5.842% | |
| 0% | |
| 0% |